U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ACHIRAL
Molecular Formula C17H16Cl2N2O5
Molecular Weight 399.225
Optical Activity NONE
Defined Stereocenters 0 / 0
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of CLEFAMIDE

SMILES

OCCN(CC1=CC=C(OC2=CC=C(C=C2)[N+]([O-])=O)C=C1)C(=O)C(Cl)Cl

InChI

InChIKey=ODCUSWJXZDHLKV-UHFFFAOYSA-N
InChI=1S/C17H16Cl2N2O5/c18-16(19)17(23)20(9-10-22)11-12-1-5-14(6-2-12)26-15-7-3-13(4-8-15)21(24)25/h1-8,16,22H,9-11H2

HIDE SMILES / InChI

Molecular Formula C17H16Cl2N2O5
Molecular Weight 399.225
Charge 0
Count
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 0
Optical Activity NONE

Clefamide is an aromatic ether and antiprotozoal agent that was used to treat and chemoprophylaxis of amoebiasis in the 1960s

Approval Year

Patents

Patents

Substance Class Chemical
Created
by admin
on Mon Mar 31 18:16:41 GMT 2025
Edited
by admin
on Mon Mar 31 18:16:41 GMT 2025
Record UNII
4AZ2V8K4EK
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
CLEFAMIDE
INN   MART.   WHO-DD  
INN  
Official Name English
CHLORPHENOXAMIDE [MI]
Preferred Name English
clefamide [INN]
Common Name English
CLEFAMIDE [MART.]
Common Name English
Clefamide [WHO-DD]
Common Name English
2,2-DICHLORO-N-(2-HYDROXYETHYL)-N-(P-(P-NITROPHENOXY)BENZYL)ACETAMIDE
Common Name English
Classification Tree Code System Code
NCI_THESAURUS C277
Created by admin on Mon Mar 31 18:16:41 GMT 2025 , Edited by admin on Mon Mar 31 18:16:41 GMT 2025
WHO-ATC P01AC02
Created by admin on Mon Mar 31 18:16:41 GMT 2025 , Edited by admin on Mon Mar 31 18:16:41 GMT 2025
Code System Code Type Description
WIKIPEDIA
CLEFAMIDE
Created by admin on Mon Mar 31 18:16:41 GMT 2025 , Edited by admin on Mon Mar 31 18:16:41 GMT 2025
PRIMARY
INN
1522
Created by admin on Mon Mar 31 18:16:41 GMT 2025 , Edited by admin on Mon Mar 31 18:16:41 GMT 2025
PRIMARY
CAS
3576-64-5
Created by admin on Mon Mar 31 18:16:41 GMT 2025 , Edited by admin on Mon Mar 31 18:16:41 GMT 2025
PRIMARY
SMS_ID
100000080191
Created by admin on Mon Mar 31 18:16:41 GMT 2025 , Edited by admin on Mon Mar 31 18:16:41 GMT 2025
PRIMARY
MERCK INDEX
m644
Created by admin on Mon Mar 31 18:16:41 GMT 2025 , Edited by admin on Mon Mar 31 18:16:41 GMT 2025
PRIMARY Merck Index
PUBCHEM
71819
Created by admin on Mon Mar 31 18:16:41 GMT 2025 , Edited by admin on Mon Mar 31 18:16:41 GMT 2025
PRIMARY
EPA CompTox
DTXSID30189296
Created by admin on Mon Mar 31 18:16:41 GMT 2025 , Edited by admin on Mon Mar 31 18:16:41 GMT 2025
PRIMARY
MESH
C024701
Created by admin on Mon Mar 31 18:16:41 GMT 2025 , Edited by admin on Mon Mar 31 18:16:41 GMT 2025
PRIMARY
EVMPD
SUB06647MIG
Created by admin on Mon Mar 31 18:16:41 GMT 2025 , Edited by admin on Mon Mar 31 18:16:41 GMT 2025
PRIMARY
NCI_THESAURUS
C78099
Created by admin on Mon Mar 31 18:16:41 GMT 2025 , Edited by admin on Mon Mar 31 18:16:41 GMT 2025
PRIMARY
FDA UNII
4AZ2V8K4EK
Created by admin on Mon Mar 31 18:16:41 GMT 2025 , Edited by admin on Mon Mar 31 18:16:41 GMT 2025
PRIMARY
DRUG BANK
DB13512
Created by admin on Mon Mar 31 18:16:41 GMT 2025 , Edited by admin on Mon Mar 31 18:16:41 GMT 2025
PRIMARY
ECHA (EC/EINECS)
222-694-6
Created by admin on Mon Mar 31 18:16:41 GMT 2025 , Edited by admin on Mon Mar 31 18:16:41 GMT 2025
PRIMARY
ChEMBL
CHEMBL1788400
Created by admin on Mon Mar 31 18:16:41 GMT 2025 , Edited by admin on Mon Mar 31 18:16:41 GMT 2025
PRIMARY
DRUG CENTRAL
4393
Created by admin on Mon Mar 31 18:16:41 GMT 2025 , Edited by admin on Mon Mar 31 18:16:41 GMT 2025
PRIMARY
Related Record Type Details
ACTIVE MOIETY